Zoledronic Acid Activates the DNA S-Phase Checkpoint and Induces Osteosarcoma Cell Death Characterized by Apoptosis-Inducing Factor and Endonuclease-G Translocation Independently of p53 and Retinoblastoma Status | Molecular Pharmacology
Drug Criteria & Outcomes | 2003-09-01 | AHC Media: Continuing Medical Education Publishing | Relias Media - Continuing Medical Education Publishing
Zoledronic acid | New Drug Approvals
Metastatic Bone Disease & Role of Zoledronic Acid
Development of zoledronic acid functionalized hydroxyapatite loaded polymeric nanoparticles for the treatment of osteoporosis
Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram
Bisphosphonates as antimyeloma drugs | Leukemia
Mechanism of action of denosumab compared to zoledronic acid. Notes:... | Download Scientific Diagram
Zoledronic acid - Wikipedia
Improved Process for Zoledronic Acid Synthesis | SpringerLink
Zoledronic acid - Wikipedia
Zoledronic Acid | SpringerLink
Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment? | Breast Cancer Research | Full Text
Various pathways of zoledronic acid against osteoclasts and bone cancer metastasis: a brief review | BMC Cancer | Full Text
Mechanistic insights into how Zoledronate attenuates Arthritis: Zoledronate (also known as Zoledronic acid) (brand name: Reclast, Zometa and others), used to treat bone diseases, including osteoporosis, high blood calcium & bone breakdown
Denosumab: mechanism of action and clinical outcomes - Hanley - 2012 - International Journal of Clinical Practice - Wiley Online Library
Zoledronic Injection Manufacturer & Supplier India | Buy Online
Zoledronic acid | C5H10N2O7P2 - PubChem
Bisphosphonates: Mechanism of Action and Role in Clinical Practice - Mayo Clinic Proceedings
Cancers | Free Full-Text | Osteoporosis: A Long-Term and Late-Effect of Breast Cancer Treatments | HTML
Possible mechanism of action of zoledronic acid and denosumab. | Download Scientific Diagram
Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions - ScienceDirect
Possible ocular adverse effects attributable to bisphosphonate therapy: Two case reports | Revista Colombiana de Reumatología (English Edition)
